Skip to content

Kuwanon E sensitizes hepatocellular carcinoma cells to disulfidptosis via MTOR-mediated autophagy blockade.

Sep 2026 · Biochemical Pharmacology · Vol 254, pp. 118499 · 0 citations · 53 references
Medicine

TL;DR

Kuwanon E (KE) is identified as the most potent sensitizer of disulfidptosis in HCC cells and is established as a functional disulfidptosis-sensitizing agent from a natural source, providing a compelling mechanistic rationale for targeting disulfidptosis to overcome metabolic and autophagic resistance in HCC.

Abstract

Disulfidptosis, a recently identified form of regulated cell death driven by toxic intracellular disulfide accumulation and subsequent collapse of the actin cytoskeleton, represents a promising therapeutic vulnerability in hepatocellular carcinoma (HCC), particularly for tumors exhibiting metabolic reprogramming and resistance to conventional apoptosis-based therapies. In this study, we screened eleven representative bioactive constituents derived from Cortex Mori, including stilbenoids, flavonoids, coumarins, and phenolic acids, under glucose deprivation conditions that trigger disulfidptosis, and identified Kuwanon E (KE) as the most potent sensitizer of disulfidptosis in HCC cells. Integrative network pharmacology, RNA sequencing, and untargeted metabolomics revealed that KE preferentially targets the MTOR signaling pathway and autophagic flux. Mechanistically, KE significantly prolonged the half-life of MTOR protein without altering its mRNA expression, leading to MTOR accumulation. This was accompanied by a blockade of autophagic flux at the autophagosome-to-lysosome fusion step, as evidenced by increased p62 and LC3-II protein levels and accumulation of mRFP-GFP-LC3 puncta. This autophagic stagnation resulted in profound depletion of glutathione (GSH) and NADPH, shifting the redox balance toward disulfide formation and promoting non-reducible cross-linking of key cytoskeletal proteins FLNA and DREBRIN, ultimately leading to actin network collapse and cell death. Importantly, co-treatment with the MTOR inhibitor/autophagy inhibitor activator rapamycin or exogenous GSH supplementation effectively rescued KE-mediated disulfidptosis sensitization, confirming the functional centrality of MTOR signaling and GSH metabolism. These findings establish KE as a functional disulfidptosis-sensitizing agent from a natural source and provide a compelling mechanistic rationale for targeting disulfidptosis to overcome metabolic and autophagic resistance in HCC.

View source

Similar papers

Open access Aug 2026

Autophagic flux inhibition potentiates disulfidptosis susceptibility in human hepatocellular carcinoma

Disulfidptosis is a newly recognized form of non-classical cell death, characterized by the abnormal accumulation of disulfide bonds and the collapse of the cytoskeleton. Nevertheless, the regulatory mechanisms governing this process are not fully understood. Although autophagy is a crucial cellular process necessary...

Meng-Jiao Shi, Liang-Wen Yan, Kai-Ling Hu et al. · 0 citations
Review Open access Sep 2026

Disulfidptosis: molecular mechanisms and therapeutic targets

Cell death is essential for maintaining internal stability and metabolic balance in the human body and plays a key role in regulating physiological and pathological processes. Advances in understanding the link between pathological mechanisms and cell death have provided new insights into diagnosis and treatment. A nov...

Cong Wang, Jia-Lin Zhou, Bing-Hui Jin et al. · 0 citations
Sep 2026

Indole-benzimidazole hybrids modulate lipid metabolism and promote autophagic and apoptotic signaling in breast cancer.

The findings demonstrate that indole-benzimidazole hybrids function as multifunctional modulators of breast cancer cell metabolism by coordinately targeting lipid homeostasis, sphingolipid-associated signaling, autophagic regulation, and apoptosis.

E. Acikgoz, Mustafa Çakır, B. Kuzu · 0 citations
Sep 2026

Nucleolin shields PTBP1 from autophagic degradation to sustain gemcitabine resistance in bladder cancer.

Chemoresistance is a principal cause of treatment failure in bladder cancer (BLCA), yet the mechanisms that actively maintain resistance remain poorly defined. Gemcitabine (GEM) resistance is classically attributed to impaired drug uptake via human equilibrative nucleoside transporter 1 (hENT1) and activation of pro-su...

Yunyi Liu, Ya-Tao Wu, Juan Li et al. · 0 citations
Sep 2026

Discovery of a Novel HDAC1 Inhibitor to Potentiate Ferroptosis with Arachidonic Acid in ESCC

Ferroptosis represents a promising therapeutic strategy for esophageal squamous cell carcinoma (ESCC), but its efficacy is often limited by intrinsic metabolic defenses. Herein, arachidonic acid (AA) acts as a potent sensitizer for class I histone deacetylase (HDAC) inhibitor-induced ferroptosis. Guided by the bindin...

Meng Liu, Shan Gao, Chen Chen et al. · 0 citations
Sep 2026

HCE6-mediated photodynamic therapy induces hepatocellular carcinoma cell death via inhibition of autophagic flux.

Porphyrin derivatives are potential candidates for photodynamic therapy against cancer. In this study, hydrophilic chlorin e6 trisodium salt (HCE6) was selected for treatment of hepatocellular carcinoma (HCC). SK-hep1 cells and a xenograft mouse model were used to investigate the antitumor efficacy and the autophagic m...

Xin Jiang, Ke-Yi Zhou, Xin-Tian Huang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.